Sangamo selects winning bids in Chapter 11 asset auction for USD 163.55 million cash at close
Reuters2026/08/12 20:28- Sangamo Therapeutics selected winning bids in a court-supervised Chapter 11 asset auction totaling USD 163.55 million cash at closing.
- PTC Therapeutics set to buy the Fabry disease program ST-920 for USD 111 million, with up to USD 100 million tied to FDA approvals.
- Eli Lilly to acquire capsid delivery, zinc finger, MINT platforms, and prion program ST-506 for USD 50 million in cash.
- Separate sales of tools and equipment expected to add USD 2.55 million in cash proceeds at closing.
- Transactions await U.S. Bankruptcy Court sign-off; Lilly closing targeted around Sept. 4, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
"Smart money" makes massive purchases of U.S. stocks! Bank of America clients record the sixth highest weekly net purchases in history, technology stocks favored again
According to the latest client fund flow data from Bank of America, last week its clients recorded a net purchase of U.S. stocks for the second consecutive week, with the inflow reaching the highest level since mid-July. This marks the sixth largest single-week net inflow since the bank began tracking weekly data in 2008.

UBS lifts Azelis stake above 3% voting rights threshold again, filing shows